CAT placental levels were significantly different among groups (p < 0.05), with both COVID-19 groups showing a significant decrease in the post-hoc analysis, compared to controls (asymptomatic: p = 0.03; symptomatic: p = 0.02) (Figure 2A). This evidence concerns the gene CAT and COVID-19.